Trial · NCT07055607
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
NCT07055607, Enrolling by invitation, Novo Nordisk A/S
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice. Trials, record NCT07055607. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07055607
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
- NCT number
- NCT07055607
- Status
- Enrolling by invitation
- Enrollment
- 1,250 participants, estimated
- Lead sponsor
- Novo Nordisk A/S
- Conditions
- Obesity
- Interventions
- Semaglutide
- First posted
- 2025-07-09
- Last updated
- 2026-08-04
Source ClinicalTrials.gov
Registered outcomes47
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Absolute change in body weight (kilograms [kg]) | From baseline (0 months) to the end of observation (24 months) | Measured in kg. |
| Primary | Percentage change in body weight (percentage [%]) | From baseline (0 months) to the end of observation (24 months) | Measured in %. |
| Secondary | Absolute change in waist circumference (centimeters [cm]) | From baseline (0 months) to the end of observation (24 months) | Measured in cm. |
| Secondary | Absolute change in waist-to-height ratio | From baseline (0 months) to the end of observation (24 months) | Measured as ratio. |
| Secondary | Percentage change in waist circumference (%) | From baseline (0 months) to the end of observation (24 months) | Measured in %. |
| Secondary | Number of participants who achieve greater than or equal to (>=) 5 percent body weight reduction (Yes/No) | From baseline (0 months) to the end of observation (24 months) | Measured as count of participants. |
| Secondary | For Switzerland: Number of participants who achieve >=7 percent body weight reduction (Yes/No) | From baseline (0 months) to the end of observation (22 months) | Measured as count of participants. |
| Secondary | Number of participants who achieve >=10 percent body weight reduction (Yes/No) | From baseline (0 months) to the end of observation (24 months) | Measured as count of participants. |
| Secondary | For Switzerland: Number of participants who achieve >=12 percent body weight reduction (Yes/No) | From baseline (0 months) to the end of observation (22 months) | Measured as count of participants. |
| Secondary | Number of participants who achieve >=15 percent body weight reduction (Yes/No) | From baseline (0 months) to the end of observation (24 months) | Measured as count of participants. |
1 to 10 of 47Source ClinicalTrials.gov
See all 47 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07055607
GET https://conductscience.org/api/trials/v1/NCT07055607/registered?page=2